Development and clinical application of hydrogel formulations containing papain and urea for wound healing
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/212210 |
Resumo: | Hydrogels are used for wound treatment, as they may contain one or more active components and protect the wound bed. Papain is one of the active substances that have been used with this purpose, alongside urea. In this paper, carboxypolymethylene hydrogels containing papain (2% and 10% concentrations) and urea (5% concentration) were produced. Physical-chemical stability was performed at 0, 7, 15 and 30 days at 2-8ºC, 25ºC and 40ºC, as well as the rheological aspects and proteolytic activity of papain by gel electrophoresis. Clinical efficacy of the formulations in patients with lower limb ulcers was also evaluated in a prospective, single-center, randomized, double-blind and comparative clinical trial. The results showed 7-day stability for the formulations under 25ºC, in addition to approximately 100% and 15% of protein activity for 10% and 2% papain hydrogel, respectively. The rheological profile was non-Newtonian for the 10% papain hydrogel tested. There were no significant differences regarding the mean time for healing of the lesions, although 10% papain presented a better approach to be used in all types of tissue present in the wound bed. |
id |
USP-31_36cb4db7b8a5e8e69d58c091082bd483 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/212210 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Development and clinical application of hydrogel formulations containing papain and urea for wound healingWound healingHydrogelPapainUreaElectrophoresisHydrogels are used for wound treatment, as they may contain one or more active components and protect the wound bed. Papain is one of the active substances that have been used with this purpose, alongside urea. In this paper, carboxypolymethylene hydrogels containing papain (2% and 10% concentrations) and urea (5% concentration) were produced. Physical-chemical stability was performed at 0, 7, 15 and 30 days at 2-8ºC, 25ºC and 40ºC, as well as the rheological aspects and proteolytic activity of papain by gel electrophoresis. Clinical efficacy of the formulations in patients with lower limb ulcers was also evaluated in a prospective, single-center, randomized, double-blind and comparative clinical trial. The results showed 7-day stability for the formulations under 25ºC, in addition to approximately 100% and 15% of protein activity for 10% and 2% papain hydrogel, respectively. The rheological profile was non-Newtonian for the 10% papain hydrogel tested. There were no significant differences regarding the mean time for healing of the lesions, although 10% papain presented a better approach to be used in all types of tissue present in the wound bed.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-05-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21221010.1590/s2175-97902023e201090Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/212210/194323Copyright (c) 2023 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMenezes dos Santos, Thaisde Sousa, Danieli Silva Feijó di Piero, Karina ChammaTodeschini, Adriane ReginaDias, Wagner BarbosaOliveira, Catarina Amorim Pereira dos Santos, ElisabeteMonteiro, Mariana Sato de Souza BustamanteGomes, Maria KátiaMoura, Cristiano dos ReisTeixeira, Pedro Antônio CasteloRicci-Junior, Eduardode Freitas, Zaida Maria Faria2023-05-22T14:04:05Zoai:revistas.usp.br:article/212210Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-22T14:04:05Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
title |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
spellingShingle |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing Menezes dos Santos, Thais Wound healing Hydrogel Papain Urea Electrophoresis |
title_short |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
title_full |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
title_fullStr |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
title_full_unstemmed |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
title_sort |
Development and clinical application of hydrogel formulations containing papain and urea for wound healing |
author |
Menezes dos Santos, Thais |
author_facet |
Menezes dos Santos, Thais de Sousa, Danieli Silva Feijó di Piero, Karina Chamma Todeschini, Adriane Regina Dias, Wagner Barbosa Oliveira, Catarina Amorim Pereira dos Santos, Elisabete Monteiro, Mariana Sato de Souza Bustamante Gomes, Maria Kátia Moura, Cristiano dos Reis Teixeira, Pedro Antônio Castelo Ricci-Junior, Eduardo de Freitas, Zaida Maria Faria |
author_role |
author |
author2 |
de Sousa, Danieli Silva Feijó di Piero, Karina Chamma Todeschini, Adriane Regina Dias, Wagner Barbosa Oliveira, Catarina Amorim Pereira dos Santos, Elisabete Monteiro, Mariana Sato de Souza Bustamante Gomes, Maria Kátia Moura, Cristiano dos Reis Teixeira, Pedro Antônio Castelo Ricci-Junior, Eduardo de Freitas, Zaida Maria Faria |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Menezes dos Santos, Thais de Sousa, Danieli Silva Feijó di Piero, Karina Chamma Todeschini, Adriane Regina Dias, Wagner Barbosa Oliveira, Catarina Amorim Pereira dos Santos, Elisabete Monteiro, Mariana Sato de Souza Bustamante Gomes, Maria Kátia Moura, Cristiano dos Reis Teixeira, Pedro Antônio Castelo Ricci-Junior, Eduardo de Freitas, Zaida Maria Faria |
dc.subject.por.fl_str_mv |
Wound healing Hydrogel Papain Urea Electrophoresis |
topic |
Wound healing Hydrogel Papain Urea Electrophoresis |
description |
Hydrogels are used for wound treatment, as they may contain one or more active components and protect the wound bed. Papain is one of the active substances that have been used with this purpose, alongside urea. In this paper, carboxypolymethylene hydrogels containing papain (2% and 10% concentrations) and urea (5% concentration) were produced. Physical-chemical stability was performed at 0, 7, 15 and 30 days at 2-8ºC, 25ºC and 40ºC, as well as the rheological aspects and proteolytic activity of papain by gel electrophoresis. Clinical efficacy of the formulations in patients with lower limb ulcers was also evaluated in a prospective, single-center, randomized, double-blind and comparative clinical trial. The results showed 7-day stability for the formulations under 25ºC, in addition to approximately 100% and 15% of protein activity for 10% and 2% papain hydrogel, respectively. The rheological profile was non-Newtonian for the 10% papain hydrogel tested. There were no significant differences regarding the mean time for healing of the lesions, although 10% papain presented a better approach to be used in all types of tissue present in the wound bed. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-05-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/212210 10.1590/s2175-97902023e201090 |
url |
https://www.revistas.usp.br/bjps/article/view/212210 |
identifier_str_mv |
10.1590/s2175-97902023e201090 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/212210/194323 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023) Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023) Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222918116900864 |